Model DetailsMammary gland adenocarcinoma
Model Name |
Mammary gland adenocarcinoma | Strain |
(C57BL/6N x C3H/HeN)F1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
mammary adenocarcinoma • mammary gland adenocarcinoma • mammary gland (malignant) neoplasm • mammary adca |
Strain Synonyms |
BCF1 • B6C3F1 • C57BL/6NxC3H/HeN F1 • B6C3F1 • (C57BL/6N X C3H/HeN)F1 |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Mammary gland | Male |
0% (0 of 244 mice) |
2 years |
|
Tamano S, Toxicol Pathol 1988;16(3):321-6 |
| Mammary gland | Female |
1.2% (3 of 246 mice) |
2 years |
|
Tamano S, Toxicol Pathol 1988;16(3):321-6 |
| Mammary gland | Female |
6.7% (1 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Mammary gland | Female |
35.7% (5 of 14 mice) |
36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Mammary gland | Female |
3.1% (1 of 32 mice) |
24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Mammary gland | Female |
12.3% (9 of 73 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Mammary gland | Female |
15.8% (3 of 19 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Mammary gland | Female |
7.7% (1 of 13 mice) |
24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Mammary gland | Female |
13.6% (3 of 22 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Mammary gland | Female |
17.6% (3 of 17 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Mammary gland | Female |
10.1% (26 of 258 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Mammary gland | Male |
0% (0 of 245 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |